Research Article
Volume 4 Issue 5 - 2020
Percutaneous Vertebroplasty in Traumatic Vertebral Compression Fractures: Analysis of 371 Cases
Оleksandr S Voloshchuk1* and Olena P Krasylenko2
1NeuroTrauma Department, Romodanov Neurosurgery Institute, Kyiv, Ukraine
2Department of Miniinvasive and Laser Spinal Neurosurgery, Romodanov Neurosurgery Institute, Kyiv, Ukraine
*Corresponding Author: Оleksandr S Voloshchuk, NeuroTrauma Department, The State Institution Romodanov Neurosurgery Institute National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.
Received: March 13, 2020; Published: April 29, 2020




Abstract

Objectives: The evaluation of short- and long-term results of percutaneous vertebroplasty in patients with isolated traumatic vertebral compression fractures: the dynamics of pain intensity, motor activity and quality of life.

Methods: The short-term and long-term clinical results of percutaneous vertebroplasty (PV) in patients with isolated traumatic vertebral compression fractures (IT VCF) (n = 371) were analyzed, the patients were divided into two groups. Group I - the patients with a high-energy injury to the spine with absent osteoporosis signs (n = 160); Group II - the patients with IT VCF due to minor injury against osteoporosis background (n = 211).

Results: The most significant changes in the rate of back pain, related indicators of motor activity and quality of life (according to Oswestry questionnaire) occur during the first 3 days after PV. Thus, average pain intensity index that characterized the pain as very severe before surgery (8,22 ± 1,39 points in group I and 8,44 ± 1.16 points in group II), after 3 days decreased by 9 and 7,7 times, respectively, to values corresponding to minor pain (0,91 ± 1,01 and 1,1 ± 1,02 points, respectively).

The average motor activity score decreased 5,9 times in group I (from 8,82 ± 1,39 to 1,49 ± 0,76 points); in group II - 5,1 times (from 8,82 ± 1,45 to 1,73 ± 1,01 points). Oswestry Disability Index (ODI), which after the severe trauma corresponded to severe disability in group I (57,7 ± 20,2) and injury - in group II (61,6 ± 17,4), indicated moderate disability in group I 3 days after PV (31,2 ± 16,4) and was on the verge of moderate and severe disability (40,4 ± 14,5) in group II. Further improvement of most of these indicators in the first half-year is progressing gradually.

During the long-term period, the intensity of pain in group I increased insignificantly (from 0,74 ± 0,76 points in 1 year to 0,82 ± 0,89 points after 3 years), in group II it increased statistically significantly (p < 0,05) (from 0,91 ± 0,87 points after 1 year to 2,15 ± 1,02 points after 3 years). The average motor activity score in group I increased insignificantly (from 1,11 ± 0,38 to 1,33 ± 0,63), in group II it increased statistically significantly (p < 0,05) (from 1,80 ± 1, 01 to 2,59 ± 1,16). ODI in group I remains at 16,7 ± 16,4 (minimal disability), in group II it increases insignificantly within the values corresponding to moderate disability (from 24,6 ± 16,0 to 27,8 ± 17,4).

Conclusion: The rate, completeness and stability of recovery of the functional state are slightly higher in patients of group I. In addition, clinical symptoms, spondylographic and densitometric examination in group I indicate the progression of age-related degenerative changes of the spine, in group II - the prevalence of osteoporotic spondylopathy against these changes.

Keywords: Traumatic Vertebral Compression Fractures; Percutaneous Vertebroplasty; Pain; Quality of Life; Motor Activity

References

  1. Fitzharris M., et al. “Estimating the global incidence of traumatic spinal cord injury”. Spinal Cord 52.2 (2014): 117-122. 
  2. Pedachenko EG and Kushchaev SV. “Punkciina vertebroplastika [Punctive vertebroplasty]”. Кiev: А.L. D. Publication (2005).
  3. Khyzhnyak МV., et al. “Long-term results of treatment the traumatic fractures of vertebral by рunctive percutaneous methods”. Journal of Clinical and Experimental Medicine Research 2.4 (2014): 513-517. 
  4. Pedachenko EG., et al. “Traumatic injuries of the spine and spinal cord”. Кiev: Intarservis (2017).
  5. Chen LX., et al. “Comparative efficacy and tolerability of three treatments in old people with osteoporotic vertebral compression fracture: a network meta-analysis and systematic review”. PLoS One 10.4 (2015): e0123153. 
  6. Zhao S., et al. “Comparison of the efficacy and safety of 3 treatments for patients with osteoporotic vertebral compression fractures”. Medicine (Baltimore) 96.26 (2017): e7328.
  7. Anderson PA., et al. “Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures”. Journal of Bone and Mineral Research 28.2 (2013): 372-382.
  8. Liu J., et al. “Comparing pain reduction following vertebroplasty and conservative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials”. Pain Physician 16.5 (2013): 455-464.
  9. Yuan WH., et al. “Vertebroplasty and balloon kyphoplasty versus conservative treatment for osteoporotic vertebral compression fractures: a meta-analysis”. Medicine (Baltimore) 95.31 (2016): e4491.
  10. Teyssédou S., et al. “Kyphopasty and vertebroplasty”. Orthopaedics and Traumatology: Surgery and Research 100.1 (2014): S169-S179. 
  11. Boonen S., et al. “Balloon kyphoplasty and vertebroplasty in the management of vertebral compression fractures”. Osteoporosis International 22.12 (2011): 2915-2934. 
  12. Klazen CA., et al. “Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): An open-label randomised trial”. Lancet 376.9746 (2010): 1085-1092.
  13. Anselmetti GC., et al. “Pain relief following percutaneous vertebroplasty: Results of a series of 283 consecutive patients treated in a single institution”. CardioVascular and Interventional Radiology 30.3 (2007): 441-447. 
  14. Rousing R., et al. “Twelve-months follow-up in forty-nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: A clinical randomized study”. Spine (Phila Pa 1976) 35.5 (2010): 478-482.
  15. Xie L., et al. “Percutaneous vertebroplasty versus conservative treatment for osteoporotic vertebral compression fractures: An updated meta-analysis of prospective randomized controlled trials”. International Journal of Surgery 47 (2017): 25-32. 
  16. Gu CN., et al. “Outcomes of vertebroplasty compared with kyphoplasty: a systematic review and meta-analysis”. Journal of NeuroInterventional Surgery 8.6 (2016): 636-642. 
  17. Zuo XH., et al. “Network meta-analysis of percutaneous vertebroplasty, percutaneous kyphoplasty, nerve block, and conservative treatment for non-surgery options of acute/subacute and chronic osteoporotic vertebral compression fractures (OVCFs) in short-term and long-term effects”. Medicine (Baltimore) 97.29 (2018): e11544. 
  18. Lamanna A., et al. “Vertebroplasty for acute painful osteoporotic vertebral compression fractures: An update”. Journal of Medical Imaging and Radiation Oncology 63.6 (2019): 779-785. 
  19. McGirt MJ., et al. “Vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: An evidenced-based review of the literature”. Spine Journal 9.6 (2009): 501-508. 
  20. Tan HY., et al. “A prospective study of percutaneous vertebroplasty for chronic painful osteoporotic vertebral compression fracture”. Pain Research and Management 20.1 (2015): e8-e11.
  21. Khan M and Kushchayev SV. “Percutaneous Vertebral Body Augmentations: The State of Art”. Neuroimaging Clinics of North America 29.4 (2019): 495-513. 
  22. Takura T., et al. “Cost-Effectiveness Analysis of Percutaneous Vertebroplasty for Osteoporotic Compression Fractures”. Clinical Spine Surgery 30.3 (2017): E205-E210. 
  23. Edidin AA., et al. “Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures”. Applied Health Economics and Health Policy 10.4 (2012): 273-284. 
  24. Omidi-Kashani F., et al. “Does percutaneous kyphoplasty have better functional outcome than vertebroplasty in single level osteoporotic compression fractures? A comparative prospective study”. Journal of Osteoporosis (2013): 5.
  25. Fairbank JC., et al. “The Oswestry low back pain disability questionnaire”. Physiotherapy 66.8 (1980): 271-273. 
  26. Pekkanen L., et al. “Reliability and validity study of the finish version 2.0 of the Oswestry disability index”. Spine (Phila Pa 1976) 36.4 (2011): 332-338.
  27. Firanescu CE., et al. “Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): Randomised sham controlled clinical trial”. British Medical Journal 361 (2018): k1551. 
  28. Buchbinder R., et al. “Percutaneous vertebroplasty for osteoporotic vertebral compression fracture”. Cochrane Database of Systematic Reviews 11 (2018): CD006349. 
  29. Lamanna A., et al. “Vertebroplasty for acute painful osteoporotic vertebral compression fractures: An update”. Journal of Medical Imaging and Radiation Oncology 63 (2019): 779-785. 
  30. Epstein NE. “A Comparison of Kyphoplasty, Vertebroplasty, or Non-Surgical Treatment of Traumatic/Atraumatic Osteoporotic Vertebral Compression Fractures: A Short Review”. Surgical Neurology International 10.54 (2019): 1-5. 
  31. Lou S., et al. “Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials”. Osteoporosis International 30.12 (2019): 2369-2380. 
  32. Magerl F., et al. “A comprehensive classification of thoracic and lumbar injuries”. European Spine Journal 3.4 (1994): 184-201. 
  33. Bousson V., et al. “Percutaneous Vertebral Augmentation Techniques in Osteoporotic and Traumatic Fractures”. Seminars in Interventional Radiology 35.4 (2018): 309-323. 
Citation: Оleksandr S Voloshchuk and Olena P Krasylenko. “Percutaneous Vertebroplasty in Traumatic Vertebral Compression Fractures: Analysis of 371 Cases”. EC Emergency Medicine and Critical Care 4.5 (2020): 33-41.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk